Heron Therapeutics | HRTX - 負債

株価
0.81
毎日の変更
0.03 4.24%
毎月
-25.50%
毎年
-66.58%
Q1 予測
0.76




負債 変化する 日付
ALKERMES USD 71.6M 1.08M 2025-09
Alnylam Pharmaceuticals USD 1.31B 11.39M 2025-09
Amarin USD 0 0 2025-03
ANI Pharmaceuticals USD 617.04M 3.28M 2025-12
Anika Therapeutics USD 0 0 2025-03
Arrowhead Research USD 366.28M 13.25M 2025-09
Eisai JPY 236.67B 49.14B 2025-09
Emergent BioSolutions USD 903.2M 495.2M 2023-06
Esperion Therapeutics USD 262.92M 1.76M 2024-09
GlaxoSmithKline GBP 17.75B 396M 2025-09
Heron Therapeutics USD 149.65M 157K 2024-09
Insmed USD 727.89M 163.33M 2025-12
Ligand Pharmaceuticals USD 451M 445.26M 2025-09
Merck USD 41.37B 5.97B 2025-09
Nektar Therapeutics USD 0 0 2022-06
Neurocrine Biosciences USD 428.4M 10.7M 2025-09
Omeros USD 442.16M 199K 2023-09
Pacira USD 372.19M 4.53M 2025-12
Regeneron Pharmaceuticals USD 2.71B 400K 2025-09
Roche Holding CHF 33.03B 1.41B 2025-06
Sangamo BioSciences USD 0 0 2022-06
Surmodics USD 29.55M 111K 2024-09
Ultragenyx Pharmaceutical USD 33.83M 2.46M 2025-09
Veracyte USD 40.45M 10.19M 2025-09
Vertex Pharmaceuticals USD 1.83B 307.4M 2025-09